Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenxuan Zang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos Computational Biology|March 17, 2026
TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomicsChenxuan Zang, Charles C Guo, Yaohong Wang, et al.
BMC Bioinformatics|March 25, 2021
m<sup>7</sup>GDisAI: N7-methylguanosine (m<sup>7</sup>G) sites and diseases associations inference based on heterogeneous networkJiani Ma, Lin Zhang, Jin Chen, et al.
Plos Computational Biology|February 11, 2026
A comparative study of statistical methods for identifying differentially expressed genes in spatial transcriptomicsYishan Wang, Chenxuan Zang, Ziyi Li, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
A comparative study of statistical methods for identifying differentially expressed genes in spatial transcriptomicsYishan Wang, Chenxuan Zang, Ziyi Li, et al.
Contemporary Clinical Trials|August 2, 2021
The use of real-world data/evidence in regulatory submissionsFuyu Song, Chenxuan Zang, Xinyi Ma, et al.
Human Pathology|August 8, 2025
Mixed-grade papillary urothelial carcinoma with a minor high-grade component shows a significantly worse clinical outcome than low-grade papillary urothelial carcinomaWilliam Mi, Chenxuan Zang, Jianping Zhao, et al.
Haematologica|March 26, 2026
Monitoring relapse in post-transplant acute myeloid leukemia requires integrated assessment, with flow cytometry showing the highest efficacyWei J Wang, Sa A Wang, Hong Fang, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Cellular stemness identifies high-risk ductal carcinoma <i>in situ</i> and offers a therapeutic interception opportunityE Schueddig, V Kochat, E Arslan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos Computational Biology|March 17, 2026
TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomicsChenxuan Zang, Charles C Guo, Yaohong Wang, et al.
BMC Bioinformatics|March 25, 2021
m<sup>7</sup>GDisAI: N7-methylguanosine (m<sup>7</sup>G) sites and diseases associations inference based on heterogeneous networkJiani Ma, Lin Zhang, Jin Chen, et al.
Plos Computational Biology|February 11, 2026
A comparative study of statistical methods for identifying differentially expressed genes in spatial transcriptomicsYishan Wang, Chenxuan Zang, Ziyi Li, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
A comparative study of statistical methods for identifying differentially expressed genes in spatial transcriptomicsYishan Wang, Chenxuan Zang, Ziyi Li, et al.
Contemporary Clinical Trials|August 2, 2021
The use of real-world data/evidence in regulatory submissionsFuyu Song, Chenxuan Zang, Xinyi Ma, et al.
Human Pathology|August 8, 2025
Mixed-grade papillary urothelial carcinoma with a minor high-grade component shows a significantly worse clinical outcome than low-grade papillary urothelial carcinomaWilliam Mi, Chenxuan Zang, Jianping Zhao, et al.
Haematologica|March 26, 2026
Monitoring relapse in post-transplant acute myeloid leukemia requires integrated assessment, with flow cytometry showing the highest efficacyWei J Wang, Sa A Wang, Hong Fang, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Cellular stemness identifies high-risk ductal carcinoma <i>in situ</i> and offers a therapeutic interception opportunityE Schueddig, V Kochat, E Arslan, et al.
Pageof 1